ArticleCardiovascular diabetology2025

Real-world cardiovascular effectiveness of sustained glucagon-like peptide 1 GLP-1 receptor agonist usage in type 2 diabetes.

Kathrine Kold Sørensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.